Recently Updated Guidelines
Guidelines for Treatment of Cancer by Type
-
Anal Carcinoma Version 3.2025
-
Biliary Tract Cancers Version 1.2025
-
Bladder Cancer Version 1.2025
-
Breast Cancer Version 3.2025
-
Central Nervous System Cancers Version 5.2024
-
Cervical Cancer Version 4.2025
-
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 3.2025
-
Colon Cancer Version 2.2025
-
Esophageal and Esophagogastric Junction Cancers Version 2.2025
-
Gastric Cancer Version 2.2025
-
Hepatocellular Carcinoma Version 1.2025
-
Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Version 2.2025
-
Neuroendocrine and Adrenal Tumors Version 1.2025
-
Pediatric Acute Lymphoblastic Leukemia Version 3.2025
-
Pediatric Aggressive Mature B-Cell Lymphomas Version 1.2025
-
Primary Cutaneous Lymphomas Version 2.2025
-
Rectal Cancer Version 2.2025
-
Small Bowel Adenocarcinoma Version 3.2025
-
Systemic Light Chain Amyloidosis Version 2.2025
-
Testicular Cancer Version 2.2025
-
Thyroid Carcinoma Version 1.2025
-
Wilms Tumor (Nephroblastoma) Version 1.2025
-
NCCN Guidelines with Evidence Blocks - Anal Carcinoma Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Biliary Tract Cancers Version 1.2025
-
NCCN Guidelines with Evidence Blocks - Breast Cancer Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Central Nervous System Cancers Version 5.2024
-
NCCN Guidelines with Evidence Blocks - Cervical Cancer Version 4.2025
-
NCCN Guidelines with Evidence Blocks - Colon Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Esophageal and Esophagogastric Junction Cancers Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Gastric Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Hepatocellular Carcinoma Version 1.2025
-
NCCN Guidelines with Evidence Blocks - Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Pediatric Acute Lymphoblastic Leukemia Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Pediatric Aggressive Mature B-Cell Lymphomas Version 1.2025
-
NCCN Guidelines with Evidence Blocks - Primary Cutaneous Lymphomas Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Rectal Cancer Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Small Bowel Adenocarcinoma Version 3.2025
-
NCCN Guidelines with Evidence Blocks - Systemic Light Chain Amyloidosis Version 2.2025
-
NCCN Guidelines with Evidence Blocks - Testicular Cancer Version 2.2025
Guidelines for Detection, Prevention, & Risk Reduction
-
Breast Cancer Screening and Diagnosis Version 2.2025
-
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric Version 4.2024
-
Prostate Cancer Early Detection Version 1.2025
Guidelines for Supportive Care
-
Adult Cancer Pain Version 1.2025
-
Antiemesis Version 1.2025
-
Palliative Care Version 2.2025
-
Survivorship Version 1.2025